Trial Details

TERMINATED
Basic Information
Clinical ID c4320
Identifier NCT00707512
Trial Title CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: natalizumab
Participant Information
Sponsor Biogen
City Scottsdale
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2008-06-30
Primary Completion Date 2015-05-28
Completion Date 2015-05-28